Market Size of Cell Therapy Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 17.05 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Cell Therapy Market Analysis
The cell therapy market is expected to witness a CAGR of 17.05% over the forecast period.
The impact of the COVID-19 pandemic on the cell therapy market is expected to be significant as most companies have been focusing on the development of cell-based therapies for COVID-19 treatment. For instance, in April 2020, Calidi Biotherapeutics Inc. revealed that the Investigational New Drug (IND) application submitted by its partner, Personalized Stem Cells Inc. (PSC), received the Food and Drug Administration approval for the treatment of COVID-19 and pneumonia patients using stem cell therapy. The impact of COVID-19 is also expected to have a positive impact on the studied market as most pharmaceutical, biotechnology, and research institutes have been focusing on the development of cell therapy-based treatment against COVID-19. For instance, according to the study published in Stem Cell Research & Therapy volume on 'When stem cells meet COVID-19: recent advances, challenges and future perspectives' published in January 2022, stem cell therapy and stem cell-derived organoid models have got a lot of attention as a new treatment and research method for COVID-19, and stem cells play a role in the battle against COVID-19. This will open up further opportunities for the market players to launch new products, which is expected to drive the market growth during the forecast period.
The cell therapy market is anticipated to witness healthy growth due to the increasing prevalence of chronic conditions, rising adoption of regenerative medicine, and rise in the number of clinical studies about the development of cellular therapies.
Chronic diseases and conditions are on the rise worldwide. As per the International Diabetes Federation Diabetes Altas, in 2021, nearly 573 million adults globally were living with diabetes worldwide, and the number is expected to reach 643 million by 2030 and 783 million by 2045.
Therefore, the increasing prevalence of chronic conditions, government assistance, and numerous companies investing heavily in stem cell therapy research and development are predicted to stimulate industry growth. The proven effectiveness of cell therapy products, coupled with the increasingly favorable guidelines on cell therapy research and manufacturing, is likely to positively impact the market growth over the forecast period. On the other hand, the high cost associated with cell therapies is expected to hinder market growth.
Cell Therapy Industry Segmentation
As per the scope of the report, cell therapy is known as a type of therapy in which live cells are injected into a patient for the treatment of a number of disorders by replacing diseased or dysfunctional cells with healthy functioning ones. Some of the cells used for the treatment include hematopoietic (blood-forming) stem cells (HSC), skeletal muscle stem cells, mesenchymal stem cells, lymphocytes, dendritic cells, and pancreatic islet cells, among others. The cell therapy market is segmented by type (autologous and allogeneic), therapy (mesenchymal stem cell therapy, fibroblast cell therapy, hematopoietic stem cell therapy, and other therapies), application (musculoskeletal, malignancies, cardiovascular, dermatology and wounds, and other applications) and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for all the above segments. The market report also covers the estimated market sizes and trends for 17 different countries across the major regions globally.
| Type | |
| Autologous | |
| Allogeneic |
| Therapy | |
| Mesenchymal Stem Cell Therapy | |
| Fibroblast Cell Therapy | |
| Hematopoietic Stem Cell Therapy | |
| Other Therapies |
| Application | |
| Musculoskeletal | |
| Malignancies | |
| Cardiovascular | |
| Dermatology and Wounds | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Cell Therapy Market Size Summary
The cell therapy market is poised for significant growth, driven by the increasing prevalence of chronic diseases and the rising adoption of regenerative medicine. The market is experiencing a surge in interest due to the proven effectiveness of cell therapy products and favorable guidelines supporting research and manufacturing. The COVID-19 pandemic has further accelerated market developments, as companies and research institutions have focused on cell-based therapies to combat the virus, opening new avenues for product launches. The market's expansion is also supported by the growing number of clinical studies and government assistance, although high costs associated with cell therapies remain a challenge.
North America is expected to maintain its dominant position in the cell therapy market, supported by a robust regulatory framework, the presence of key industry players, and leading research institutions. The region's growth is fueled by increased investments in cell-based therapies and positive clinical outcomes, such as improved survival rates in cancer treatments. The market is moderately competitive, with major companies engaging in strategic initiatives like research and development, acquisitions, and collaborations to strengthen their market presence. These factors collectively contribute to the anticipated steady growth of the cell therapy market over the forecast period.
Cell Therapy Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Prevalence of Chronic Conditions
-
1.2.2 Rising Adoption of Regenerative Medicine
-
1.2.3 Rise in Number of Clinical Studies Pertaining to the Development of Cellular Therapies
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Therapies
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 Type
-
2.1.1 Autologous
-
2.1.2 Allogeneic
-
-
2.2 Therapy
-
2.2.1 Mesenchymal Stem Cell Therapy
-
2.2.2 Fibroblast Cell Therapy
-
2.2.3 Hematopoietic Stem Cell Therapy
-
2.2.4 Other Therapies
-
-
2.3 Application
-
2.3.1 Musculoskeletal
-
2.3.2 Malignancies
-
2.3.3 Cardiovascular
-
2.3.4 Dermatology and Wounds
-
2.3.5 Other Applications
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle-East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle-East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Cell Therapy Market Size FAQs
What is the current Cell Therapy Market size?
The Cell Therapy Market is projected to register a CAGR of 17.05% during the forecast period (2024-2029)
Who are the key players in Cell Therapy Market?
PHARMICELL Co., Ltd , Corestem Inc., Chiesi Farmaceutici S.p.A., Tego Science and Anterogen Co., Ltd. are the major companies operating in the Cell Therapy Market.
